Journals / Bakırköy Tıp Dergisi / 2019 / Cilt: 15 - Sayı: 4

Experimental Animal Models Used to Develop Polycystic Ovarian Syndrome

Polikistik Over Sendromu Oluşturmak için Kullanılan Deneysel Hayvan Modelleri

Pages
333–338
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

It has been observed that classical polycystic ovarian morphology can be formed in these ovaries by experimental methods and many hormonal imbalances observed in PCOS were noticed.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Polycystic ovary syndrome (PCOS) is the most common endocrine and metabolic disorder in women of reproductive age.
📊
Key Findings & Data:Obesity, dyslipidemia, impaired glucose tolerance and type 2 diabetes are important clinical problems in patients with PCOS.
💡
Conclusion & Impact:It has been observed that classical polycystic ovarian morphology can be formed in these ovaries by experimental methods and many hormonal imbalances observed in PCOS were noticed.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Polycystic ovary syndrome (PCOS) is the most common endocrine and metabolic disorder in women of reproductive age. Obesity, dyslipidemia, impaired glucose tolerance and type 2 diabetes are important clinical problems in patients with PCOS. Furthermore, PCOS is a significant risk factor for cardiovascular diseases and endometrial cancer in the long term. Although a number of genetic and environmental factors have been reported in the development, the underlying pathophysiological mechanism remains unclear. In PCOS, which has an active field of research in gynecology, the lack of consensus on the diagnostic criteria leads to be published of contradictory publications on such a frequent systemic disorder. For this reason, it is very important to reveal the exact pathogenesis of the disease with animal models. The purpose of this review is to summarize the experimental models used to induce PCOS. It has been observed that classical polycystic ovarian morphology can be formed in these ovaries by experimental methods and many hormonal imbalances observed in PCOS were noticed.

Özet

Polikistik Over sendromu (PKOS) üreme çağındaki kadınlarda en sık karşılaşılan endokrin ve metabolik bozukluktur. Obezite, dislipidemi, bozulmuş glukoz toleransı ve tip 2 diyabet PKOS’li hastalarda sık görülen önemli klinik sorunlardır. Ayrıca PKOS uzun dönemde kalp damar hastalıkları ve endometriyum kanseri için anlamlı bir risk faktörüdür. Gelişiminde bir takım genetik ve çevresel faktörler bildirilmesine rağmen, altta yatan patofizyolojik mekanizma açık değildir. Jinekolojide aktif bir araştırma alanı bulan PKOS’de, tanı kriterleri üzerinde tam bir fikir birliği olmaması böylesine sık karşılaşın sistemik bir bozuklukla ilgili çelişkili yayınların basılmasına neden olmaktadır. Bu nedenle hastalığın gerçek patogenezinin hayvan modelleri ile ortaya konulması oldukça önemlidir. Bu derlemede amacımız, PKOS oluşturmak için kullanılan deneysel modelleri özetlemektir. Bahsedeceğimiz bu yöntemlerle deneysel olarak overlerde klasik polikistik over morfolojisi oluşturulabildiği ve PKOS’deki çoğu hormonal dengesizliğin izlendiği gözlemlenmiştir.

🔖

Cite This Article

TOKMAK, A., ERSAK, D. T., ŞAHİN, A. (2019). Experimental Animal Models Used to Develop Polycystic Ovarian Syndrome. Bakırköy Tıp Dergisi, Cilt: 15 - Sayı: 4, 333–338. https://ajindex.com/articles/131950

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. March WA, Moore VM, Willson KJ, Phillips DI, Norman RJ, Davies MJ. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod 2010;25:544-51
  2. Sanchón R, Gambineri A, Alpañés M, Martínez-García MÁ, Pasquali R, Escobar-Morreale HF. Prevalence of functional disorders of androgen excess in unselected premenopausal women: a study in blood donors. Hum Reprod 2012;27:1209-16
  3. Stein IF, Leventhal M. Amenorrhea associated with bilateral polycystic ovaries. Am J Obstet Gynecol 1935;29:181-91
  4. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004;81:19-25
  5. Agacayak E, Tunc SY, Sak S, Basaranoglu S, Yüksel H, Turgut A, et al. Levels of Neopterin and other Inflammatory Markers in Obese and Non-Obese Patients with Polycystic Ovary Syndrome. Med Sci Monit 2015;21:2446-55
  6. Homburg R. Pregnancy complications in PCOS. Best Pract Res Clin Endocrinol Metab 2006;20:281-92
  7. Alvarez-Blasco F, Botella-Carretero JI, San Millán JL, Escobar- Morreale HF. Prevalence and characteristics of the polycystic ovary syndrome in overweight and obese women. Arch Intern Med 2006;166:2081-6
  8. Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev 1997;18:774-800
  9. Salley KE, Wickham EP, Cheang KI, Essah PA, Karjane NW, Nestler JE. Glucose intolerance in polycystic ovary syndrome--a position statement of the Androgen Excess Society. J Clin Endocrinol Metab 2007;92:4546-56
  10. Wild RA, Carmina E, Diamanti-Kandarakis E, Dokras A, Escobar- Morreale HF, Futterweit W, et al. Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society. J Clin Endocrinol Metab 2010;95:2038-49
  11. Vgontzas AN, Legro RS, Bixler EO, Grayev A, Kales A, Chrousos GP. Polycystic ovary syndrome is associated with obstructive sleep apnea and daytime sleepiness: role of insulin resistance. J Clin Endocrinol Metab 2001;86:517-20
  12. Berni TR, Morgan CL, Berni ER, Rees DA. Polycystic ovary syndrome is associated with adverse mental health and neurodevelopmental outcomes. J Clin Endocrinol Metab 2018;103:2116-25
  13. Murri M, Luque-Ramírez M, Insenser M, Ojeda-Ojeda M, Escobar- Morreale HF.